Abstract
p53 is a transcription factor, which is encoded by the TP53 gene in human. p53 regulates the cell cycle and functions as a tumour suppressor, thus, involved in preventing cancer. In vivo, analysis of p53 mechanisms in whole animal models are critical, alternatively Drosophila can be selected. Our present study worked on comparative and interactome profiling of p53 protein using PyMol and Haddock 2.4. The structural similarity resulted that p53 of Drosophila (Dmp53) is almost alike to that of human p53 (Hp53) protein. Hp53 interacting proteins were systematically docked and analyzed with Hp53 and Dmp53 both. Furthermore the associated complexes are analysed through Discovery Studio. The interactome study revealed better homologous interaction like human p53. Drosophila p53 exhibits characteristics that makes it a promising model for cancer research, bearing resemblance to human p53.
Similar content being viewed by others
AVAILABILITY OF DATA AND MATERIALS
The data that supports the findings of this study are available in the supplementary material of this article.
REFERENCES
Bourdon, J.C., Deguin-Chambon, V., Lelong, J.C., Dessen, P., May, P., Debuire, B., and May, E., Further characterisation of the p53 responsive element—identification of new candidate genes for trans-activation by p53, Oncogene, 1997, vol 14, pp. 85–94.
Canman, C.E., Lim, D.S., Cimprich, K.A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M.B., and Siliciano, J.D., Activation of the ATM kinase by ionizing radiation and phosphorylation of p53, Science, 1998, vol. 281, pp. 1677–1679.
Chakraborty, R., Li, Y., Zhou, L., and Golic, K.G., Corp regulates p53 in Drosophila melanogaster via a negative feedback loop, PLoS Genet., 2015, vol. 11, no. 7, p. e1005400.
De Leo, A.B., Jay, G., Appella, E., Dubois, G.C., Law, L.W., and Old, L.J., Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse, Proc. Natl. Acad. Sci. U. S. A., 1997, vol. 76, pp. 2420–2424.
Edelman, J. and Nemunaitis J., Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region, Curr. Opin. Mol. Ther., 2003, vol. 5, pp. 611—617.
El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W., and Vogelstein, B., Definition of a consensus binding site for p53, Nat. Genet., 1992, vol. 1, pp. 45–49.
El-Deiry, W.S., Tokino, T., Velculescu, V.E, Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression, Cell, 1993, vol. 75, pp. 817–825.
Ferreira, C.G., Tolis, C., and Giaccone, G., p53 and chemosensitivity, Ann. Oncol., 1999 vol. 10, pp. 1011–1021.
Funk, W.D., Pak, D.T., Karas, R.H., Wright, W.E., and Shay, J.W., A transcriptionally active DNA binding site for humanp53 protein complexes, Mol Cell Biol., 1992, vol. 12, pp. 2866–2871.
Hekmat-Nejad, M., You, Z., Yee, M.C., Newport, J.W., and Cimprich, K.A., Xenopus ATR is a replication dependent chromatin-binding protein required for the DNA replication checkpoint, Curr. Biol., 2006, vol. 10, pp. 1565–1573.
Herzog, G., Joerger, A.C., Shmueli, M.D., Fersht, A.R., Gazit, E., and Segal, D., Evaluating Drosophila p53 as a model system for studying cancer mutations, J. Biol. Chem., 2012, vol. 287, no. 53, pp. 44330–44337. https://doi.org/10.1074/jbc.M112.417980
Isobe, M., Emanuel, B.S., Givol, D., Oren, M., and Croce, C.M., Localization of gene for human p53 tumour antigen to band 17p13, Nature, 1986, pp. 32084–32085.
Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F., and Sherr, C.J., Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2, Proc. Natl. Acad. Sci. U. S. A., 1998, vol. 95, no. 14, pp. 8292–8297. https://doi.org/10.1073/pnas.95.14.8292
Kastan, M.B. et al., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia, Cell, 1992 vol. 71, pp. 587–597. https://doi.org/10.1016/0092-8674(92)90593-2
Kress, M., May, E., Cassingena, R., and May, P., Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum, J. Virol., 1979, vol. 31, pp. 472–483.
Lane D., p53 from pathway to therapy, Carcinogenesis, 2004, vol. 25, pp. 1077–1081.
Lane, D.P. and Crawford, L.V., T antigen is bound to a host protein in SV40-transformed cells, Nature, 1979, vol. 278, pp. 261–263.
Lane D.P., Cancer. p53, guardian of the genome, Nature, 1992, vol. 358, pp. 15–16.
Lee J.H. et al., In vivo p53 function is indispensable for DNA damage-induced apoptotic signaling in Drosophila, FEBS Lett., 2003, vol. 550, pp. 5–10.
Linzer D.I.H. and Levine A.J., Characterization of a 54 K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and in infected embryonal carcinoma cells, Cell, 1979, vol. 1, pp. 43–52.
Lu, W.-J., Amatruda, J.F., and Abrams, J.M., p53 ancestry: gazing through an evolutionary lens, Nat. Rev. Cancer., 2009, vol. 9, pp. 758–762.
Matlashewski, G., Lamb, P., Pim, D., Peacock, J., Crawford, L., and Benchimol, S., Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene, EMBO J., 1984, vol. 3, pp. 3257–3262.
Melero, J.A., Stitt, D.T., Mangel, W.F., and Carroll, R.B., Identification of new polypeptide species (48–55 K) immunoprecipitable by antiserum to purified large T antigen and present in simian virus 40-infected and transformed cells, J. Virol., 1979, vol. 93, pp. 466–480.
Nakano, K. and Vousden, K.H., PUMA, anovelproapoptotic gene, is induced by p53, Mol. Cell, 2001, vol. 7, pp. 683–694.
Kern, S.E., Kinzler, K.W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B., Identification of p53 as a sequence-specific DNA-binding protein, Science, 1991, vol. 252, pp. 1708–1711.
Rudrapatna, V.A., Cagan, R.L., and Das, T.K., Drosophila cancer models, Dev. Dyn., 2012, vol. 241, pp. 107–118.
Rutkowski, R., Hofmann, K., and Gartner, A., Phylogeny and function of the invertebrate p53 superfamily, Cold Spring Harb. Perspect. Biol., 2010, vol. 2, p. a001131.
Sogame, N., Kim, M., and Abrams, J.M., Drosophila p53 preserves genomic stability by regulating cell death, Proc. Natl. Acad. Sci. U. S. A., 2003, vol. 100, pp. 4696–4701.
Soussi, T., Caron de Fromentel, C., and May, P., Structural aspects of the p53 protein in relation to gene evolution, Oncogene, 1990, vol. 5, pp. 945–952.
Yang, A., Kaghad, M., Caput, D., and McKeon, F., On the shoulders of giants: p63, p73 and the rise of p53, Trends Genet., 2002, vol. 18, pp. 90–95.
Yetao Jin, Hunjoo Lee, Shelya X. Zeng, Mu-Shui Dai, and Hua Lu, MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation, EMBO J., 2003, vol. 22, pp. 6365–6377.
Yamamura, R., Ooshio, T., and Sonoshita, M., Tiny Drosophila makes giant strides in cancer research, Cancer Sci., 2021, vol 112, no. 2, pp. 505–514. https://doi.org/10.1111/cas.14747
van Zundert, G.C.P., Rodrigues, J.P.G.L.M., Trellet, M., Schmitz, C., Kastritis, P.L., Karaca, E., Melquiond, A.S.J., van Dijk, M., de Vries S.J, and Bonvin A.M.J.J., The HADDO-CK2.2 webserver: user-friendly integrative modeling of biomolecular complexes, J. Mol. Biol., 2016, vol. 428, pp. 720–725.
ACKNOWLEDGMENTS
This work was supported by Oriental Institute of Science and Technology in the frame of our Research Programme.
Funding
This work was supported by ongoing institutional funding. No additional grants to carry out or direct this particular research were obtained.
Author information
Authors and Affiliations
Contributions
The Study and Method development by A.S.P and B.B, material preparation, analyzing data by N.T, experiments performed A.S and S.M, interpreted the results B.B and A.S.P and manuscript is written by A.S.P.
Corresponding author
Ethics declarations
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
This article does not contain studies with human or animal subjects performed by any of the authors that should be approved by Ethics Committee.
CONFLICT OF INTEREST
The authors of this work declare that they have no conflicts of interest.
Additional information
Publisher’s Note.
Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Figs. 1–10. Representation of Bond interactome involving ATM, BCL2, CDK2, CDKN1, CHEK2, EP300, MDM2, MDM4, CREB and TP73 with Human p53 and Drosophila p53.
Rights and permissions
About this article
Cite this article
Nutan Tudu, Sarkar, A., Mondal, S. et al. In-silico Evaluation of Structurally Homologous Drosophila p53 with Human p53 to Identify Functional Differences for Future Therapeutic Research. Biol Bull Russ Acad Sci 50 (Suppl 3), S310–S316 (2023). https://doi.org/10.1134/S1062359021101738
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062359021101738